Public Health Expertise (PHE) joins Cencora's Global Consulting Services
Enhancing our support for pharmaceutical, biotech, and medtech companies
We are excited to announce that Public Health Expertise (PHE), a France-based life sciences consulting firm specializing in market access, real-world evidence, and health economics and outcomes research, has joined forces with Cencora's Global Consulting Services. This strategic partnership significantly enhances our capabilities to support pharmaceutical, biotech, and medtech companies across Europe.
By integrating PHE's in-country expertise with Cencora’s robust capabilities, we are now better equipped to address your evolving needs in the dynamic pharmaceutical landscape. This collaboration allows us to offer more comprehensive in-market solutions, including regulatory affairs, pharmacovigilance, exploitant status services, and development consulting.
By integrating PHE's in-country expertise with Cencora’s robust capabilities, we are now better equipped to address your evolving needs in the dynamic pharmaceutical landscape. This collaboration allows us to offer more comprehensive in-market solutions, including regulatory affairs, pharmacovigilance, exploitant status services, and development consulting.
“This addition is a significant milestone for our market access team, empowering us to better serve our clients and aligns with our strategic vision," noted Tommy Bramley, Senior Vice President of Market Access and Healthcare Consulting. "By combining PHE’s in-country expertise with Cencora’s robust capabilities, we are now better equipped and strategically well-positioned to navigate a dynamic and evolving pharmaceutical landscape, including the upcoming implementation of the Joint Clinical Assessment (JCA) process starting in January 2025. Collectively we strive to accelerate innovations, optimize access, and maximize outcomes for patients.”
Tommy Bramley, Senior Vice President, Market Access and Healthcare Consulting, Cencora
Tommy Bramley, Senior Vice President, Market Access and Healthcare Consulting, Cencora
Discover our market access and healthcare consulting capabilities
At Cencora, we provide a broad range of market access and healthcare consulting services that strive for accelerated speed to market and better healthcare outcomes. We are confident that the integration of PHE into Cencora will bring significant benefits to your organization, enhancing our ability to support your market access strategies in France and beyond.
- Market access strategy: We develop tailored strategies to help you navigate complex market access landscapes, ensuring your products reach the right patients at the right time.
- Real-world evidence: Our team generates real-world evidence to demonstrate the value and effectiveness of your products, supporting reimbursement and market access decisions.
- Health economics and outcomes research: We conduct robust health economics and outcomes research to showcase the economic value and impact of your products on patient health outcomes.
- Regulatory affairs: Our regulatory experts guide you through the regulatory process, ensuring compliance and facilitating successful product approvals.
- Pharmacovigilance: We provide comprehensive pharmacovigilance services to monitor the safety of your products and ensure regulatory compliance.
- Exploitant status services: Our exploitant status services support the commercial distribution and management of your products in the market.
- Clinical services: We offer strategic consulting services to support your product development from early-stage research to commercialization.
